Text Correction
In the original publication [], a correction has been made to Section 3.7, Paragraph 1. The revised version is as follows:
Figure 8 shows the current response of a blank control (a young man’s serum), a Non-AD patient, and an AD patient (IBlank control < INon-AD patient < IAD patient). In Table 3, we chose five Non-AD patients and AD patients. Their tau381 levels are represented by the mean value ± SD. The detection contents of Non-AD patients ranged from 100 ± 6 pM to 520 ± 74 pM, and AD patients ranged from 1778 ± 86 pM to 4612 ± 62 pM, suggesting that the aptasensor could screen patients with AD and Non-AD, in excellent agreement with the results from an ELISA kit.
Error in Table
In the original publication [], there was a mistake in Table 3 as published. When two different methods were used to test the same batch of samples, the data obtained were identical. Subsequently, we carefully verified the data and corrected Table 3 based on the feedback from the Editorial Office. The corrected Table 3 appears below.
Table 3.
Assay results of clinical serum samples using aptasensor and ELISA Kit.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Reference
- Tao, D.; Shui, B.; Gu, Y.; Cheng, J.; Zhang, W.; Jaffrezic-Renault, N.; Song, S.; Guo, Z. Development of a Label-Free Electrochemical Aptasensor for the Detection of Tau381 and its Preliminary Application in AD and Non-AD Patients’ Sera. Biosensors 2019, 9, 84. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).